As of Apr 20
| +0.13 / +0.50%|
The 5 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 28.00, with a high estimate of 35.00 and a low estimate of 15.00. The median estimate represents a +6.75% increase from the last price of 26.23.
The current consensus among 7 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.